Published in J Neuropsychiatry Clin Neurosci on January 01, 1995
Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord (2005) 1.32
Depression in Parkinson's disease: health risks, etiology, and treatment options. Neuropsychiatr Dis Treat (2008) 1.01
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol (2010) 1.00
CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach. Expert Rev Neurother (2008) 0.99
A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease. PLoS One (2013) 0.94
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol (2002) 0.88
Behavioral disturbances in Parkinson's disease. Dialogues Clin Neurosci (2004) 0.76
Mood Disorders in Neurologic Illness. Curr Treat Options Neurol (2000) 0.75
The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol (1998) 7.43
Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med (2000) 3.59
Responsiveness of functional status in low back pain: a comparison of different instruments. Pain (1996) 3.52
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
[The Cochrane Collaboration; systematic reviews of knowledge from randomized studies]. Ned Tijdschr Geneeskd (1995) 2.56
Systematic review of randomized clinical trials of surgical treatment for carpal tunnel syndrome. Br J Surg (2001) 2.49
Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc (2000) 2.39
High cholesterol levels in patients with panic disorder. Am J Psychiatry (1992) 2.25
A patient-specific approach for measuring functional status in low back pain. J Manipulative Physiol Ther (1999) 2.18
Prolonged cough and lung cancer: the need for more general practice research to inform clinical decision-making. Br J Gen Pract (1997) 1.96
Behavioral-graded activity compared with usual care after first-time disk surgery: considerations of the design of a randomized clinical trial. J Manipulative Physiol Ther (2000) 1.80
Flexion and rotation of the trunk and lifting at work are risk factors for low back pain: results of a prospective cohort study. Spine (Phila Pa 1976) (2000) 1.75
The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry (2004) 1.73
The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol (2001) 1.69
The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry (2000) 1.66
The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord (2000) 1.65
Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster? Psychiatry Res (1990) 1.59
Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology (2000) 1.59
Conservative treatment for repetitive strain injury. Scand J Work Environ Health (2001) 1.53
[Depression following a first heart infarct; similarities with and differences from 'ordinary' depression]. Ned Tijdschr Geneeskd (1997) 1.43
Interobserver reliability of diagnostic criteria for cervicogenic headache. Cephalalgia (1999) 1.43
Psychosocial work characteristics and psychological strain in relation to low-back pain. Scand J Work Environ Health (2001) 1.43
Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia (1993) 1.41
Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms. Aliment Pharmacol Ther (2003) 1.41
The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis. Fam Pract (1999) 1.40
[Mania: clinical aspects, cause and treatment]. Ned Tijdschr Geneeskd (1994) 1.40
Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology (2002) 1.40
Measuring the functional status of patients with low back pain. Assessment of the quality of four disease-specific questionnaires. Spine (Phila Pa 1976) (1995) 1.39
Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach. J Neuropsychiatry Clin Neurosci (1993) 1.28
Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther (1974) 1.23
Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. Biochem Pharmacol (1971) 1.23
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology (Berl) (1999) 1.22
Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study. Lancet (1978) 1.19
Is there a relation between the seriousness of suicidal intent and the lethality of the suicide attempt? Psychiatry Res (1989) 1.18
Efficacy of traction for non-specific low back pain: a randomised clinical trial. Lancet (1995) 1.16
The efficacy of traction for back and neck pain: a systematic, blinded review of randomized clinical trial methods. Phys Ther (1995) 1.16
Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic review. Ann Rheum Dis (2000) 1.06
The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment. Nutr Neurosci (2001) 1.06
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study. Acta Psychiatr Scand (1981) 1.05
Anxiety, impulsivity and depressed mood in relation to suicidal and violent behavior. Acta Psychiatr Scand (1993) 1.05
Interconvertability of five self-report measures of depression. Psychiatry Res (1987) 1.04
A self-report measure of violence risk, II. Compr Psychiatry (1990) 1.04
The prognosis of ankle sprains. Int J Sports Med (1997) 1.03
Brain correlates of memory dysfunction in alcoholic Korsakoff's syndrome. J Neurol Neurosurg Psychiatry (1999) 1.02
Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. Stat Med (1988) 1.01
Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome. Int J Geriatr Psychiatry (2000) 1.01
The role of serotonin in schizophrenia. Schizophr Bull (1988) 1.00
Significance of cocaine history in schizophrenia. J Nerv Ment Dis (1990) 0.99
Impact of spinal cord stimulation on sensory characteristics in complex regional pain syndrome type I: a randomized trial. Anesthesiology (2001) 0.99
Cerebral monoamines and depression. An investigation with the Probenecid technique. Arch Gen Psychiatry (1973) 0.99
5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature (1970) 0.98
Management of depression with serotonin precursors. Biol Psychiatry (1981) 0.97
Correlates of suicide and violence risk: III. A two-stage model of countervailing forces. Psychiatry Res (1989) 0.96
Injection therapy for subacute and chronic benign low back pain. Cochrane Database Syst Rev (2000) 0.96
Depression. Lancet (1982) 0.94
Child psychiatric diagnoses in a population of Dutch schoolchildren aged 6 to 8 years. J Am Acad Child Adolesc Psychiatry (2001) 0.93
Efficacy of traction for nonspecific low back pain. 12-week and 6-month results of a randomized clinical trial. Spine (Phila Pa 1976) (1997) 0.92
Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res (1991) 0.92
Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry (1999) 0.91
Psycho-education in bipolar disorder: effect on expressed emotion. Psychiatry Res (1997) 0.91
The clinical significance of halopemide, a dopamine-blocker related to the butyrophenones. Neuropsychobiology (1984) 0.89
Depression, insight, and personality changes in Alzheimer's disease and vascular dementia. J Geriatr Psychiatry Neurol (1995) 0.89
The role of serotonin in schizophrenia. Eur Neuropsychopharmacol (1995) 0.88
Retarded depression and the dopamine metabolism. Psychopharmacologia (1971) 0.88
The therapeutic effect of short-term oral diazepam treatment on acute clinical anxiety in a crisis centre. Acta Psychiatr Scand (1974) 0.86
Low-level laser therapy in ankle sprains: a randomized clinical trial. Arch Phys Med Rehabil (1998) 0.86
A controlled study of temporal lobe structure volumes and P300 responses in schizophrenic patients with persistent auditory hallucinations. Schizophr Res (1999) 0.86
Impact of quality items on study outcome. Treatments in acute lateral ankle sprains. Int J Technol Assess Health Care (2000) 0.86
Specificity of the tryptophan depletion method. Psychopharmacology (Berl) (1999) 0.86
Serotonin and anxiety revisited. Biol Psychiatry (1988) 0.85
Neuroleptics as a guideline to biological research in psychotic disorders. Compr Psychiatry (1975) 0.85
Systematic review and collaborative recalculation of 133,693 incident cases of schizophrenia. Psychol Med (2012) 0.85
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int Clin Psychopharmacol (1996) 0.85
Splinting or surgery for carpal tunnel syndrome? Design of a randomized controlled trial [ISRCTN18853827]. BMC Neurol (2001) 0.85
Correlates of risk of suicide in violent and nonviolent psychiatric patients. Am J Psychiatry (1991) 0.84
Correlates of suicide and violence risk 1: the suicide risk measure. Compr Psychiatry (1989) 0.84
A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol Psychiatry (1971) 0.84
Kinetics of l-5-hydroxytryptophan in healthy subjects. Psychiatry Res (1982) 0.84
Central serotonin metabolism and frequency of depression. Psychiatry Res (1979) 0.84
The results of spinal cord stimulation in critical limb ischaemia: a review. Eur J Vasc Endovasc Surg (2001) 0.83
Elastic compression stockings: durability of pressure in daily practice. Vasa (1997) 0.83
Which patients with chronic reflex sympathetic dystrophy are most likely to benefit from physical therapy? J Manipulative Physiol Ther (2001) 0.83
Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Res (1998) 0.82
Primitive reflexes in Alzheimer's disease and vascular dementia. J Geriatr Psychiatry Neurol (1995) 0.82
The vital syndrome interview. A structured standard interview for the recognition and registration of the vital depressive symptom complex. Psychiatr Neurol Neurochir (1966) 0.82
Balneotherapy and quality assessment: interobserver reliability of the Maastricht criteria list and the need for blinded quality assessment. J Clin Epidemiol (1998) 0.82
Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. Am J Psychiatry (1973) 0.82
The MCPP challenge test in schizophrenia: hormonal and behavioral responses. Biol Psychiatry (1991) 0.82
Suicidal behaviors in adult psychiatric outpatients, I: Description and prevalence. Am J Psychiatry (1993) 0.82
Central monoamine deficiency in depressions: causative of secondary phenomenon? Pharmakopsychiatr Neuropsychopharmakol (1975) 0.82
Health-related quality of life in chronic refractory reflex sympathetic dystrophy (complex regional pain syndrome type I). J Pain Symptom Manage (2000) 0.82
Cerebrospinal fluid 5-hydroxyindolacetic acid and aggression: a critical reappraisal of the clinical data. Int Clin Psychopharmacol (1995) 0.82
Taking baths: the efficacy of balneotherapy in patients with arthritis. A systematic review. J Rheumatol (1997) 0.82
[Roaming through the methodology. VIII. Pilot studies: sense and nonsense]. Ned Tijdschr Geneeskd (1998) 0.81
The influence of probenecid on the metabolism of serotonin, dopamine and their precursors in man. Psychopharmacologia (1973) 0.81
Diagnosis of preclinical Alzheimer's disease in a clinical setting. Int Psychogeriatr (2001) 0.81
Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies. Drugs Aging (1995) 0.81